4//SEC Filing
Pearce Catherine 4
Accession 0001209191-23-004027
CIK 0001868734other
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 4:34 PM ET
Size
9.7 KB
Accession
0001209191-23-004027
Insider Transaction Report
Form 4
Pearce Catherine
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2023-01-11+13,235→ 144,146 total - Tax Payment
Common Stock
2023-01-11$28.75/sh−3,997$114,914→ 140,149 total - Exercise/Conversion
Restricted Stock Units
2023-01-11−13,235→ 13,236 total→ Common Stock (13,235 underlying)
Holdings
- 1,500(indirect: By Spouse)
Common Stock
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock.
- [F2]The securities are held by the Reporting Person's spouse. The Reporting Person shares voting and investment control of the shares and may be deemed to beneficially own the shares. The Reporting Person disclaims beneficial ownership of such shares except to the extent of her proportionate pecuniary interest therein.
- [F3]The RSUs vest in two equal annual installments beginning January 11, 2023, subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.
Documents
Issuer
CinCor Pharma, Inc.
CIK 0001868734
Entity typeother
Related Parties
1- filerCIK 0001898815
Filing Metadata
- Form type
- 4
- Filed
- Jan 18, 7:00 PM ET
- Accepted
- Jan 19, 4:34 PM ET
- Size
- 9.7 KB